GraceFinance · Source-backed public company research
MYRIAD GENETICS INC (MYGN)
Nasdaq · Manufacturing · In Vitro & In Vivo Diagnostic Substances
Core research established · 4/4 core data layers currently established
What MYRIAD GENETICS INC does
Overview and Mission Myriad Genetics is a leading molecular diagnostics and precision medicine company committed to advancing health and well-being for all. We develop and commercialize molecular tests that help patients and providers uncover genetic insights. Our tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care, support earlier detection, enable more precise treatment and contribute to lowering healthcare costs. Our Business Strategy Personalized molecular data and digital and virtual consumer trends are converging to transform traditional models of care.
Open the company story
The live GraceFinance page shows source-backed financial changes, management context, guidance, confirmed events, risks, and connected history only when the applicable evidence and relationships have been established. Missing research stays visible instead of being inferred.